We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Infant Stiff-Joint Syndromes Matched to Possible Genetic Origins

By LabMedica International staff writers
Posted on 25 May 2015
There are over 400 specific disorders that are, or can be, associated with multiple contractures in the newborn and a better understanding of disorders with contractures and their associated genetics is critical for accurate diagnosis and optimal treatment.

Contractures are defined as joints that have reduced range of motion due to stiffening of normally flexible tissues and proper central and peripheral nervous system development and function are required for stimulation of muscle movement. More...
Muscle tissue, ligaments, tendons, and skin require movement for normal development and function, without which, joints develop contractures.

Scientists at the Translational Genomics Research Institute (Phoenix, AZ, USA) and their Canadian colleagues describe over 50 of the more than 400 rare, but specific, disorders associated with multiple muscle contractures and stiff joints among newborns. They affect arms, legs, torsos and other parts of the body, often in combinations. These more than 50 disorders are called "X-linked" syndromes, because the genes that cause them are on the X chromosome and unaffected mothers can pass them on to their children, most often to their sons.

The study, or compilation of studies, identified 20 different genes associated with three categories of these more than 50 syndromes. One category represented more than 20 syndromes in which the responsible X-linked genes have been identified. A second category represented seven distinct reports consistent with X-linkage and present with contractures. A third category represented an additional 20 syndromes with reported contractures that are suspected to be X-linked. The study's goal was to better enable physicians and geneticists to advance new treatments that might help these children.

Judith G. Hall, MD, emerita professor of medical genetics, University of British Columbia (Vancouver, BC, Canada) and a coauthor of the study said, “Clearly, there are many different causes of stiff joints in newborns. We wanted to bring together the clinical description of each of these syndromes, and match them to genes, the biochemistry of genes, and the cellular pathways, in order to identify potential therapies.” The study was published in the May 2015 issue of American Journal of Medical Genetics.

Related Links:

Translational Genomics Research Institute
University of British Columbia 



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Staining System
RAL DIFF-QUIK
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.